| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Cahn J, Herold M, Dubrasq... |
Contribution à un concept biochimique des psychoses expérimentales. I... |
Compt. rend. Soc. de... |
1958 |
| Mörsdorf K, Bode HH |
Zur Beeinflussung der permeabilitätssteigernden Wirkung des Serotonins... |
Arch. internat. phar... |
1959 |
| Jasmin G, Bois P |
Effect of various agents on the development of kidney infarcts in rats... |
Lab. Invest. |
1960 |
| Radouco-Thomas S, Lajeune... |
The effect of Lsd-25 on calcium, 5-hydroxytryptamine and catecholamine... |
4th International co... |
1969 |
| Vaccari A, Vertua R, Furl... |
Decreased calcium uptake by rat fundal strips after pretreatment with ... |
Biochem Pharmacol |
1971 |
| Fossati C |
I Danni Provocati Dall'abuso di Bevande Alcooliche: Possibilita di Dis... |
Clin Ter |
1974 |
| Abdel AA, Bakry N |
Effect of Choroquine Phosphate on the Isolated Non-Pregnant and Pregna... |
Acta Physiol.Acad.Sc... |
1974 |
| Gillan MGC, Pollock D |
Investigation of the effects of drugs on morphine-induced contractions... |
Brit.J.Pharmacol. |
1976 |
| Levin RM, Weiss B |
Mechanism by Which Psychotropic Drugs Inhibit Adenosine Cyclic 3',5'-M... |
Mol. Pharmacol. |
1976 |
| Greengard P |
Cyclic Nucleotides and Phosphorylated Proteins as Targets for Drug Act... |
Acta Pharm. Suecica |
1977 |
| Valette G, Leclair MF |
du lysergide sur les réponses mécaniques des organes isolés de Rat aux... |
CR Acad. Sci. |
1978 |
| Green JP, Weinstein H, Ma... |
Defining the Histamine H2- Receptor in Brain: The Interaction With LSD |
QUASAR. Quantitative... |
1978 |
| Greengard P |
Cyclic nucleotides, phosphorylated proteins and the nervous system |
Federation Proc. |
1979 |
| Héry F, Simonnet G, Bourg... |
Effect Of Nerve Activity On The In Vivo Release Of [3H]serotonin Conti... |
Brain Research |
1979 |
| Levin RM, Weiss B |
Selective Binding of Antipsychotics and Other Psychoactive Agents to t... |
J.Pharmacol.Exp.Ther... |
1979 |
| Sachanska T, Haralanov H,... |
Complex Clinical, Biochemical and Electrophysiological Investigations ... |
Toxicol. |
1980 |
| Langer SZ, Moret C |
Citalopram Antagonizes The Effects Of Lsd On The Presynaptic Serotonin... |
Brit.J.Pharmacol. |
1982 |
| Langer SZ, Moret C |
Citalopram Antagonizes the Stimulation by Lysergic Acid Diethylamide o... |
J. Pharm. Exper. The... |
1982 |
| Williams M, Martin GE |
Selectivity of cyproheptadine as assessed by radioligand binding |
J. Pharm.Pharmacol. |
1982 |
| Singh YN |
Effects of kava on neuromuscular transmission and muscle contractility |
J Ethnopharmacol |
1983 |
| Leysen JE, De Chaffoy De ... |
Serotonin-s2 Receptor Binding Sites And Functional Correlates |
Neuropharmacology |
1984 |
| McNall SJ, Mansour TE |
Novel Serotonin Receptors In Fasciola: Characterization By Studies On ... |
Biochem. Pharmacol. |
1984 |
| Battaglia G, Brooks BP, K... |
Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at v... |
Eur J Pharmacol |
1988 |
| Gessa GL |
[Guidelines for the drug therapy of alcoholism] |
Recenti Prog Med |
1990 |
| Finnegan KT, Skratt JJ, I... |
The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... |
Neurosci Lett |
1990 |
| McKenna DJ, Guan XM, Shul... |
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... |
Pharmacol Biochem Be... |
1991 |
| Johnson M, Mitros K, Ston... |
Effect of flunarizine and nimodipine on the decrease in tryptophan hyd... |
J Pharmacol Exp Ther |
1992 |
| Finnegan KT, Calder L, Cl... |
Effects of L-type calcium channel antagonists on the serotonin-depleti... |
Brain Res |
1993 |
| Devane WA, Axelrod J |
Enzymatic synthesis of anandamide, an endogenous ligand for the cannab... |
Proc Natl Acad Sci U... |
1994 |
| Shih JC, Chen K, Gallaher... |
Structure and Function of Serotonin 5-HT2 Receptors |
NIDA Research Monogr... |
1994 |
| Kramer HK, Poblete JC, Az... |
3,4-Methylenedioxymethamphetamine ('Ecstasy') promotes the translocati... |
Brain Res |
1995 |
| Wichems CH, Hollingsworth... |
Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDM... |
Brain Res |
1995 |
| Denborough MA, Hopkinson ... |
Dantrolene and 'ecstasy' |
Med J Aust |
1997 |
| Denborough MA, Hopkinson ... |
Dantrolene and 'ecstasy' |
Med J Aust |
1997 |
| Williams A, Unwin R |
Prolonged elevation of serum creatine kinase (CK) without renal failur... |
Nephrol Dial Transpl... |
1997 |
| Kramer HK, Poblete JC, Az... |
Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetam... |
Neuropsychopharmacol... |
1997 |
| Kramer HK, Poblete JC, Az... |
Characterization of the translocation of protein kinase C (PKC) by 3,4... |
Neuropsychopharmacol... |
1998 |
| Beitia G, Cobreros A, Sai... |
3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: ef... |
Liver |
1999 |
| Varela-Rey M, Montiel-Dua... |
3,4-methylenedioxymethamphetamine ('Ecstasy') stimulates the expressio... |
Biochem Biophys Res ... |
1999 |
| Hanson GR, Jensen M, John... |
Distinct features of seizures induced by cocaine and amphetamine analo... |
Eur J Pharmacol |
1999 |
| Varon J, Marik PE |
The diagnosis and management of hypertensive crises |
Chest |
2000 |
| Todorovic SM, Jevtovic-To... |
Ca(v)3.2 channel is a molecular substrate for inhibition of T-type cal... |
Mol Pharmacol |
2001 |
| Krupitsky EM, Burakov AM,... |
Attenuation of ketamine effects by nimodipine pretreatment in recoveri... |
Neuropsychopharmacol... |
2001 |
| Boyer EW, Kearney S, Shan... |
Poisoning from a dietary supplement administered during hospitalizatio... |
Pediatrics |
2002 |
| van der Stelt M, Veldhuis... |
Acute neuronal injury, excitotoxicity, and the endocannabinoid system |
Mol Neurobiol |
2002 |
| Gudelsky GA, Yamamoto BK |
Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetami... |
Methods Mol Med |
2002 |
| Chavkin C, Sud S, Jin W, ... |
Salvinorin A, an active component of the hallucinogenic sage salvia di... |
J Pharmacol Exp Ther |
2004 |
| Pearson JM, Hargraves TL,... |
Three fatal intoxications due to methylone |
J Anal Toxicol |
2012 |
| Wightman RS, Hoffman RS, ... |
Not your regular high: cardiac dysrhythmias caused by loperamide |
Clin Toxicol (Phila) |
2016 |
| Halberstadt AL, Klein LM,... |
Pharmacological characterization of the LSD analog N-ethyl-N-cycloprop... |
Psychopharmacology (... |
2018 |
